Company news
BioVaxys Technology Corp news in 2025
BioVaxys Technology Corp's news releases, calls and decks from 2025, newest first.
BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer
December 17, 2025
BioVaxys Strengthens Scientific Team with Addition of Former IMV Vice President of R&D
December 15, 2025
BioVaxys Technology Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement
November 19, 2025
BioVaxys Announces Extension of Life Offering Closing Date
November 11, 2025
BioVaxys announces upsizing of LIFE offering of up to $2M
October 30, 2025
BioVaxys announces conversion of debentures
October 28, 2025
BioVaxys announces conversion of debentures and grant of stock options
October 20, 2025
Annual MD&A
October 18, 2025
BioVaxys Licensee SpayVac-for-Wildlife, Inc., Reports Further Positive Single-Dose Efficacy Data for Its Immunocontraceptive Vaccine and Initiation of Regulatory Submission Process
October 14, 2025
BioVaxys appoints former Sanofi Vaccines executive to board of directors
October 8, 2025
BioVaxys announces LIFE offering
October 7, 2025
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
September 29, 2025
BioVaxys announces closing of unsecured convertible debenture offering
September 16, 2025
BioVaxys announces share consolidation
September 5, 2025
BioVaxys announces unsecured convertible debenture offering and cancellation of brokered life offering
August 27, 2025
BioVaxys announces extension of offering closing date
July 15, 2025
BioVaxys engages enclave capital LLC to act as an agent in brokered private placement offering
July 7, 2025
BioVaxys announces amended LIFE offering
June 20, 2025
BioVaxys Issues Corporate Update
June 3, 2025
BioVaxys announces consolidation and concurrent brokered private placement offering for gross proceeds of up to $3,000,000
May 30, 2025
BioVaxys and Sona Nanotech Enter Research Collaboration
May 7, 2025
BioVaxys and SpayVac-for-Wildlife Expand License Agreement Into Commercial Aquaculture
April 22, 2025
BioVaxys Technology Corp. Announces Revocation of Management Cease Trade Order and Closing of Debt Settlement Transaction
April 10, 2025
BioVaxys Technology Corp. Granted Management Cease Trade Order
March 3, 2025
BioVaxys Announces Debt Settlement Agreement, Extension of Private Placement Closing Date and Closing of The Fourth and Final Tranche of Private Placement
February 18, 2025
Decks in 2025
- Investor Presentation (November 2025)
Investor deck · 18 slides · November 2025